Clinical Trials Logo

Osteochondral Defects clinical trials

View clinical trials related to Osteochondral Defects.

Filter by:
  • None
  • Page 1

NCT ID: NCT01209390 Terminated - Clinical trials for Osteochondral Defects

A Prospective, Post-marketing Registry on the Use of ChondroMimetic for the Repair of Osteochondral Defects

OMCM
Start date: September 2010
Phase: N/A
Study type: Observational

The objective of this post-marketing study is to confirm the clinical efficacy and safety outcome of treatment with ChondroMimetic in a patient population within the proposed indication (osteochondral cartilage defects), over a 36 months post-implantation follow-up period. The primary objective is to collect post-marketing safety data in a real life setting by means of (S)ADR reporting. The secondary objectives are: - Clinical outcome as assessed by patient reported EuroQoL-5D - Structural repair as assessed by MRI - The number of treatment failures and the time to treatment failure - The ease of use of ChondroMimetic as reported by the surgeon

NCT ID: NCT00891501 Recruiting - Clinical trials for Degenerative Arthritis

The Use of Autologous Bone Marrow Mesenchymal Stem Cells in the Treatment of Articular Cartilage Defects

Start date: November 2006
Phase: Phase 2/Phase 3
Study type: Interventional

This study is conducted to assess whether implanting autologous, culture-expanded, mesenchymal stem cells obtained from the bone marrow of patients with early osteoarthritis, cartilage defects or cartilage and underlying bone and cartilage (osteochondral) defects in joints is effective in the treatment of such conditions and alleviation of patients symptoms.